Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review
Currently, neurointervention, surgery, medication, and central nervous system (CNS) stimulation are the main treatments used in CNS diseases. These approaches are used to overcome the blood brain barrier (BBB), but they have limitations that necessitate the development of targeted delivery methods....
Main Authors: | Seoyeon Won, Jeongyeon An, Hwayoung Song, Subin Im, Geunho You, Seungho Lee, Kyo-in Koo, Chang Ho Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1137096/full |
Similar Items
-
Erythropoietin Nanobots: Their Feasibility for the Controlled Release of Erythropoietin and Their Neuroprotective Bioequivalence in Central Nervous System Injury
by: Thi Huong Le, et al.
Published: (2022-03-01) -
Delivery of Therapeutic Agents to the Central Nervous System and the Promise of Extracellular Vesicles
by: Charlotte A. René, et al.
Published: (2021-04-01) -
Global Research Trends of Exosomes in the Central Nervous System: A Bibliometric and Visualized Analysis
by: Yue Zhuo, et al.
Published: (2023-06-01) -
Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances
by: Safir Ullah Khan, et al.
Published: (2022-12-01) -
Mini Review: circular RNAs as potential clinical biomarkers for disorders in the central nervous system
by: Dan eLu, et al.
Published: (2016-04-01)